Veracyte (VCYT) Shares Outstanding (2012 - 2026)

Veracyte has reported Shares Outstanding (Entity) for 15 years, with the latest figure at $80.4 million in Q2 2026.

• Shares Outstanding (Entity) for Q2 2026 came in at $80.4 million, up 2.25% year-over-year; the trailing twelve-month figure through Jun 2026 was $80.4 million (up 2.25% YoY), and the FY2025 annual result was $79.4 million, up 2.04% from the prior year.
• Shares Outstanding (Entity) climbed to $80.4 million in Q2 2026, from $79.8 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $80.4 million in Q2 2026 and troughed at $71.4 million in Q1 2022.
• A 5-year average of $75.7 million and a median of $76.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The largest YoY upside for Shares Outstanding (Entity) was 6.24% in 2022 against a maximum downside of 1.0% in 2022.
• A 5-year view of Shares Outstanding (Entity) shows it stood at $72.0 million in 2022, then grew by 1.81% to $73.3 million in 2023, then grew by 6.15% to $77.8 million in 2024, then rose by 2.04% to $79.4 million in 2025, then increased by 1.27% to $80.4 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $80.4 million in Q2 2026, $79.8 million in Q1 2026, and $79.4 million in Q4 2025.